Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 535

Showing 1-25 of 535 citing articles:

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati, Vittoria Borgonetti, Virginia Brighenti, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 310
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua D. Brown, Almut G. Winterstein
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 989-989
Open Access | Times Cited: 238
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro‐Bosso, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2478-2478
Open Access | Times Cited: 234
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 220
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C Michael White
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 7, pp. 923-934
Closed Access | Times Cited: 212
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 210
Hempseed in food industry: Nutritional value, health benefits, and industrial applications
William Leonard, Pangzhen Zhang, Danyang Ying, et al.
Comprehensive Reviews in Food Science and Food Safety (2019) Vol. 19, Iss. 1, pp. 282-308
Open Access | Times Cited: 201
Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
Radmila Pavlović, Giorgio Nenna, Lorenzo Calvi, et al.
Molecules (2018) Vol. 23, Iss. 5, pp. 1230-1230
Open Access | Times Cited: 168
Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
Christian Larsen, Jorida Shahinas
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 3, pp. 129-141
Open Access | Times Cited: 147
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Tengfei Huang, Tianqi Xu, Yangfan Wang, et al.
Autophagy (2021) Vol. 17, Iss. 11, pp. 3592-3606
Open Access | Times Cited: 147
Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 145
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martı́nez, Amaia Iriondo‐DeHond, Francesca Borrelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 142
Wnt/β-catenin-driven EMT regulation in human cancers
Wenhua Xue, Lin Yang, Chengxin Chen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 92
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 70
Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells
Na Young Kim, Chakrabhavi Dhananjaya Mohan, Gautam Sethi, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 4
Closed Access | Times Cited: 20
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Uchini S. Kosgodage, Rhys R. Mould, Aine Brigette Henley, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 127
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
Laura Orsolini, Stefania Chiappini, Umberto Volpe, et al.
Medicina (2019) Vol. 55, Iss. 9, pp. 525-525
Open Access | Times Cited: 127
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca, Meir Bialer
CNS Drugs (2020) Vol. 34, Iss. 8, pp. 795-800
Closed Access | Times Cited: 124
The Endocannabinoid System: A Target for Cancer Treatment
Chiara Laezza, Cristina Pagano, Giovanna Navarra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 747-747
Open Access | Times Cited: 122
Cannabinoid Profiling of Hemp Seed Oil by Liquid Chromatography Coupled to High-Resolution Mass Spectrometry
Cinzia Citti, Pasquale Linciano, Sara Panseri, et al.
Frontiers in Plant Science (2019) Vol. 10
Open Access | Times Cited: 121
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
Kelly A. Deabold, Wayne S. Schwark, Lisa Wolf, et al.
Animals (2019) Vol. 9, Iss. 10, pp. 832-832
Open Access | Times Cited: 121
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings
Sonja Elsaid, Stefan Kloiber, Bernard Le Foll
Progress in molecular biology and translational science (2019), pp. 25-75
Closed Access | Times Cited: 118
Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment
Michelle Murphy, Sierra Mills, Joanna Winstone, et al.
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 235-246
Open Access | Times Cited: 108
Page 1 - Next Page

Scroll to top